Indivior Pharmaceuticals (INDV) Enterprise Value (2021 - 2026)
Indivior Pharmaceuticals (INDV) recorded Enterprise Value of $4.62 billion in Q2 2026, up 247.6% from $1.33 billion a year earlier and up 30.5% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Enterprise Value (2021 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' Enterprise Value came in at $3.81 billion as of Jun 30, 2026; for FY2025, it was $4.29 billion, up 249.1% from FY2024.
- Annual Enterprise Value has a four-year compound annual growth rate of 32.1% (FY2021 to FY2025).
- Across earlier years, Enterprise Value came in at $1.23 billion in FY2024 (-26.6%), $1.67 billion in FY2023 (-19.3%), $2.08 billion in FY2022 (+47.1%) and $1.41 billion in FY2021.
- The Q2 2026 figure is the highest quarterly Enterprise Value in data going back to Q4 2021.
- On a year-over-year basis, Enterprise Value has increased for four consecutive quarters, with growth averaging 113.2% over the last seven quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 333.9% in Q1 2026, against a decline of 72.0% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.54 billion (Q1 2026), $4.29 billion (Q4 2025) and $2.57 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.62 Bn |
| Mar 31, 2026 | 3.54 Bn |
| Dec 31, 2025 | 4.29 Bn |
| Sep 30, 2025 | 2.57 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 816.05 Mn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 2.18 Bn |
| Mar 31, 2024 | 2.91 Bn |
| Dec 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Dec 31, 2021 | 1.41 Bn |
API Access
Indivior Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();